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Abstract The expression of subunit genes of the Ca 2+ channel 
complex was studied in differentiating, immortalized mouse mdg 
cells. These cells expressed a~ and o~216 transcripts of the skeletal 
muscle Ca 2+ channel genes, a cardiac Ca 2+ channel a~ subunit 
gene and several known transcript variants of skeletal, cardiac 
and brain/1 genes. The mdg mutation is retained in the 129DA 3 
cell line and occurs exclusively at nucleotide position 4010 in the 
skeletal al transcript in which a cytosine residue is deleted. In 
early stages of differentiation and fusion, Ba 2÷ currents were 
detected in dysgenic myotubes the same as the cardiac L-type 
Ca 2+ channel. These data provide specific structural evidence 
]Chaudhari, N. (1992) J. Biol. Chem. 267, 25636-25639] for the 
major genetic defect in mouse muscular dysgenesis and show a 
change in the expression levels of a~s and alO The upregulation 
of the expression of alC results in functional Ca 2÷ channel activ- 
ity, however, presumably not sufficient for excitation-contraction 
coupling. 
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1. Introduction 
Muscular dysgenesis (mdg), a spontaneous, lethal mutation 
in mice [1], was found to be transmitted asa single autosomal, 
recessive gene [2,3]. Phenotypically, the mutation appears in 
homozygous embryos as a severe general deficiency of the skel- 
etal musculature while cardiac and smooth muscles how nor- 
mal development and function [2,3]. 
Extensive functional nd molecular studies [4-8] showed that 
the probable gene defect hat is the critical locus for the devel- 
opment of the dysgenic phenotype is located in or in close 
proximity to the skeletal muscle L-type voltage-gated calcium 
channel ~ subunit gene (CACHL1A3). Apparently, normal 
level expression was found for the c~2/6 subunit (CACHL2A) 
[7]. Thus far, no studies have been conducted for detection of 
fl subunit ranscripts or proteins. In recent molecular genetic 
analyses, we assigned the CACHL1A3 gene as the mdg locus 
that resides on chromosome 1 either for human or for the 
mouse [9]. Cloning and sequencing studies of cDNAs to 
*Corresponding author. Fax: (1) (513) 558 1778. 
Abbreviations: mdg, muscular dysgenesis; L-VGCC, L-type voltage- 
gated Ca 2+ channel; nt, nucleotide. 
CACHL1A3 gene in the mdg mouse disclosed a consistently 
appearing point mutation, a cytosine deletion at nt 4010 that 
causes a frameshift and premature translation stop in the read- 
ing frame of the skeletal muscle L-VGCC cq transcript [10]. 
This observation, however, is contradictory to a previous anal- 
ysis [8] with genomic DNA for the region of the CACHL1A3 
gene, in which alterations were found in the restriction frag- 
ment length of the 5'-end and 5'-flanking region for the 
CACHL1A3 gene, providing evidence that the lack of expres- 
sion or low level expression of the c~ transcript is likely a 
consequence of a mutation in the promoter region of the gene. 
A permanent, immortalized cell line was recently established 
from the mdg mouse [11] that retains the differentiation capabil- 
ity and all functional and phenotypical characteristics of the 
dysgenic mutation. Here, we present molecular evidence that 
the dysgenic mutation is fully retained in these cells as a point 
mutation in the CACHL1A3 gene at nt position 4010 of the 
open reading frame. We observed considerable expression of 
the CACHL1A3 gene transcripts as well as transcription of the 
class C-type (cardiac) CACHL1A1 calcium channel gene. The 
transcription of the latter gene can be either due to aberrant 
differentiation [121 in mdg cells or to a 'turn-on' of a compensa- 
tory mechanism that controls the level of calcium channel tran- 
scripts. Consistent with this finding, we detected class C-type 
calcium channel activity in these mdg cells. 
2. Materials and methods 
2.1. Cell cultures 
The normal mouse muscle cell line (129CB3) and the dysgenic muscle 
line (129DA3) were grown at 34°C in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 20% fetal bovine serum and 
1.25% chicken embryo extract. Differentiation was induced by depriva- 
tion of growth factors and shifting the temperature of growth to 39°C 
[11]. The differentiation medium contained 10% horse serum and 1.25% 
chicken embryo extract in DMEM. For routine growth of the cells, 
tissue culture dishes were coated with 1% gelatine. 
2.2. RNA extraction, Northern blotting and hybridization 
Total RNA was extracted from 10 7 10 8 cells by the acidic guanidin- 
ium thiocyanate method [13]and polyA ÷ RNA was purified on oligo 
dT cellulose columns [14]. PolyA ÷ RNA (~5/~g) was denatured and 
size separated on 1.2% denaturing formaldehyde-agarose gels and 
transferred onto Hybond C filters (Amersham). Filters were hybridized 
with 32p-labeled [15] DNA probes in 50% formamide, 0.5 M NaC1, 10 
mM Na/PO4, pH 7.4, 5 mM EDTA, 0.1% SDS and 10% dextrane 
sulphate at 45°C. The highest stringency washing of filters was done 
in 150 mM NaC1, 10 mM Na/PO4, pH 7.4, 1 mM EDTA and 0.1% SDS 
at 55°C. Blots were exposed to K dak X-OMAT films at -70°C for 
various times (from 2 to 24 h). 
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2.3. PCR amplification of segments of skeletal and cardiac ot~ gene 
products 
Multiplex PCR was performed on 2 pg polyA + RNA isolated from 
non-differentiated and differentiated cultured mouse muscle cells 
(129CB3, 129DA3) and from routine muscle tissues. The first strand 
synthesis was done with 1/tg polyA ÷ RNA using 200 U of Superscript 
reverse transcriptase (GIBCO-BRL) and 6-mer random primers at 
50°C for 1 h. For the second strand synthesis and amplification, multi- 
plex PCR was performed using 2 U of Vent polymerase and three 
primers. The reverse primer was designed for a region in motif I that 
is highly homologous between skeletal [10] and cardiac ~l subunits [16]. 
This sequence lies between nts 1942-1962 and 675~595 for cardiac and 
skeletal muscle clones, respectively. The two forward primers were 
designed for a more Y-upstream sequence that is non-homologous 
between the cardiac (1249-1268) and skeletal (206-226) messages. PCR 
(Roche Molecular Systems) was done in 32 cycles including denatura- 
tion at 95°C for 2 rain, annealing at 68°C for 30 sec and extension for 
2 min at 72°C. The PCR products were separated on 2% sieving 
agarose gels. RT-PCR amplification for the motif IVSs-S 6 segment of 
both skeletal and cardiac ~ was done utilizing the same conditions as 
described for motif I regions. The primers were designed for nts 3935- 
3954 (forward) and 4108~087 (reverse) corresponding to the skeletal 
~ sequence. The PCR products were isolated from preparative gels, 
subcloned into pBluescriptSK(+) at the EcoRV site and sequenced 
using the dideoxy chain termination method [17]. 
2.4. Cell cultures for electrophysiology and electrophysiological 
recordings 
Cells were plated at very low density (100-500 cells/60 mm dish) and 
grown on glass coverslips coated with 1% gelatin. 24 h after plating, 
differentiation was induced as described above and electrophysiological 
recordings were done at a very early stage of differentiation (usually on 
the second and third day of differentiation) when most of the cells were 
in the non-fused stage or myotubes did not contain more that ~3 
nuclei/cell. Barium currents (I~) were recorded in the whole-cell config- 
uration [18] at room temperature (20-22°C). The bathing solution was 
(in mM): Ba(OH),, 40; glutamate, 40; N-methyl-I>glucamine, 80;
HEPES, 10; MgCI2, 2; pH adjusted to 7.4 with CH3SO3H. The pipette 
solution contained (in raM): N-methyl-o-glucamine, 110; MgCI> 2; 
EGTA, 15; HEPES, 15; pH adjusted to 7.3 with CH3SO3H. Pipettes had 
resistances between 3-5 MD when filled with 1 M KCI. Capacitive 
transients were minimized using the analog circuitry of the amplifier 
(Axopatch 1B, Axon Instruments, CA). Isis were recorded at various 
digitizing rates and filtered at 0.5 or 1 kHz using a four-pole Bessel 
filter. Stimulation of the cell, data acquisition and analysis were per- 
formed using the pCLAMP software package (version 5.5; Axon In- 
struments,CA). 
3. Results 
In Northern hybridizations, a skeletal muscle L-VGCC ~z~ 
(~lS) subunit probe provided clear signals with a 6.5-kb mRNA 
species for both of the differentiated 129CB 3 and 129DA3 cells. 
The hybridizing RNA band was of identical size with that 
detectable in a mouse skeletal muscle preparation. When the 
same blot was hybridized with a cardiac L-VGCC ~ (Sic) 
probe, cross-hybridization was noted with the 6.5-kb band, 
however, an 8.6-kb band was clearly detectable in differentiated 
129DA3 cells, the size of which was identical with cardiac ~1 
mRNA from mouse heart (Fig. 1). A skeletal muscle ~2 probe 
detected hybridization with an 8.5-kb message for 129CB 3 and 
129DA3 cells as well. The skeletal muscle fll~ probe cross-hy- 
bridized with four bands corresponding to RNA sizes of 1.9, 
3.5, 5.3 and 6.8 kb. These correspond to products offl~, f12, f13 
and f14 genes. The pattern of expression offl messages in immor- 
talized normal and dysgenic muscle cells is somewhat different 
from that seen in normal skeletal muscle. The immortalized 
cells express commensurable amounts of all four fl messages 
while the fit gene product is prevalent in normal skeletal muscle 
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Fig. 1. Expression of mRNAs of L-VGCC subunits in normal (129CB3) 
and dysgenic (129DA3) mouse muscle cells. PolyA + RNAs from 129CB3 
and 129DA 3 cells were hybridized with various Ca 2+ channel subunit 
cDNA probes. ND, non-differentiated; D, differentiated. The probes 
are: skeletal c~; 6.1-kb XbaI fragment of the full-length rabbit cDNA 
[19], cardiac el; 5.2-kb EcoRI fragment of the rabbit cDNA [20], skel- 
etal ez; 3.5-kb EcoRI fragment of the rabbit cDNA [19], skeletal fl; 
1.6-kb EcoRI fragment of the rabbit cDNA [21], RflA; 1.6-kb PstI 
fragment of the cross-hybridizing rat fl-actin probe [23], GAPDH; 0.7- 
kb PstI/XbaI fragment of the glyceraldehyde-3-phosphate dehydroge- 
nase cDNA [22]. 
and the expression of f12 and f13 genes is significantly lower. 
The f14 gene expression was not detectable in mouse skeletal 
muscle. 
A cross-hybridizing fl-actin gene cDNA was used to monitor 
the progress of differentiation. Hybridization with this probe 
shows that during differentiation the expression of ~-actin is 
turned on, however, fl,),-actin expression is not completely 
eliminated. This phenomenon is typical for the immortalized 
muscle cells [23]. The expression of skeletal and cardiac al 
transcrips were assessed relative to the level of the glyceralde- 
hyde-3-phosphate dehydrogenase housekeeping gene. We esti- 
mated that skeletal a~ expression was 10-30-fold lower in differ- 
entiated 129DA 3 cells compared to that of 129CB 3 normal 
mouse muscle cells. 
RT-PCR amplification of alS- and a~c-specific DNA se- 
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Fig. 2. Multiplex RT-PCR of the divergent 5'-ends of mouse skeletal 
and cardiac ~ sequences from polyA ÷ RNA, isolated from non-differ- 
entiated and differentiated cultured mouse muscle cells (129C33, 
129DA3) and from muscle tissues. (A) Three primers were used for the 
PCR (see Section 2). Amplification between these primers provide reac- 
tion products of 694 and 470 nts for cardiac and skeletal eft, respec- 
tively. (B) A region of 5'-amplified sequences ar  depicted and shown 
that they are in 100% homology with the corresponding skeletal and 
cardiac 061 sequences. 
quences was carried out on mRNA preparations from non- 
differentiated and differentiated forms of 129CB3 and 129DA3 
cells. Multiplex PCR resulted in the appearance of470 and 694 
bp products in both cell lines that are characteristic cDNA 
segments for skeletal and cardiac el, respectively (Fig. 2A). The 
DNA sequences of the PCR products howed 100% identity 
with the mouse skeletal and cardiac ~1 sequences (Fig. 2B). The 
amplifications have not been optimized on quantitative scale, 
thus no conclusions can be reached for the relative abundance 
of 0~lS and ~lC transcripts in these cells. 
PCR amplification on a segment (IVSs-IVS6, between nts 
3935-4087) resulted in the appearance of a product with 152 
bp in length both for 129CB3 and 129DA3 mRNA preparations 
(data not shown). Sequencing of the 129DA3 mRNA related 
PCR product on both strands revealed a DNA sequence that 
was 100% identical with that of the mouse ~ls except at nt 
position 4010. At this position, a deletion mutation, the lack of 
a cytosine nucleoside residue, was noted compared to the se- 
quence obtained from 129CB 3 cells and matched that published 
previously [10] (Fig. 3A). The existence and nature of this mu- 
tation was confirmed by using several different mRNA prepa- 
rations from 129CB3 and 129DA3 cells and also by independent 
amplifications of the same RNA preparation. We have found 
that the deletion mutation consistently appears in 129DA3 cells 
and never appears in the normal counterpart, in 129CB3 cells. 
The mouse ~1c sequence for this region did not show this 
mutation and was found to be fully identical with the published 
mouse cardiac el sequence (data not shown) [16]. 
The cytosine deletion at nt 4010 in the 129DA 3 ~Zl sequence 
generates a frameshift mutation in the conceptual translation. 
This frameshift generates a stop codon at nt 4173 that prema- 
turely terminates the translation of the el message. Conse- 
quently, part of the topological arrangement of the cq in motif 
IV is altered. The translation stops in the mutant mdg oq after 
the motif IV SS 1 region and the critical SS2 segment that carries 
glutamic acid residues important for Ca 2+ selectivity are missing 
[24-26]. Further, the IVS 6 and the C-terminal tail are deleted 
(Fig. 3B). 
Depolarization of voltage-clamped 129DA3 cells from a 
holding potential o f -80  mV to various test potentials from -40 
to +50 mV induced inward barium currents (IB0 in a voltage- 
dependent manner (Fig. 4A). The currents activated with fast 
kinetics and decayed following inactivation kinetics, in a man- 
ner typical for cardiac L-type IB,s. The current-voltage relation- 
ship of these current recordings is depicted in Fig. 4B. The 
currents activated at -30 mV and reached peak current values 
at + 10 mV potential. This high-voltage activated IBa was found 
to be sensitive to dihydropyridine agonists. Application of 
1/tM Bay K 8644 increased the peak current -4-fold, shifted the 
voltage-dependence of activation and inactivation to hyperpo- 
larizing potentials and accelerated inactivation (Fig. 4C). The 
IBaS also exhibited sensitivity to fl-adrenergic modulation. Iso- 
proterenol at a concentration of 10/tM increased IBa ~2-fold 
(Fig. 4D). In our experiments, we never detected slow L-type 
Isa that would be related to skeletal L-type Ca 2+ channel activ- 
ity. 
4. Discuss ion 
We have shown that the mdg mutation is molecularly re- 
tained in an immortalized cell line (129DA3) and is in the al 
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subunit of L-VGCC at nt 4010 where a cytosine residue is 
deleted. This deletion generates a frameshift that culminates at 
a premature stop codon at nt 4173. Previously, we showed for 
the genome of the mdg mouse that the genetic locus of the 
mutation is colocalized with the L-VGCC a~ subunit gene [9]. 
Further, cDNA cloning and sequencing of the mdg mouse L- 
VGCC al also identified the nature and position of mdg point 
mutation [10]. 
The mdg point mutation has widespread consequences for 
Fig. 3. (A) RT-PCR amplification f skeletal l sequences from polyA + 
RNA isolated from differentiated 129CB 3and 129DA 3cells. The prim- 
ers were designed for nts3935-3954 (forward) and 4108-4087 (reverse) 
that spans the region between IVS5 a d 1VS 6 and covers the SS1-SS2 
segments. The PCR products were subcloned and sequenced. Some 
details of the sequence are depicted on the figure. InPCR products from 
mdg cells (129DA3) a point mutation, a deletion of a cytosine residue 
was noted at nt 4010 (left, the missing CG base-pair was put in the box 
with dashed lines). In PCR products of normal mouse cells (129CB3), 
no cytosine deletion was detected (right, the base pair at4010 is boxed). 
(B) The deletion mutation at nt 4010 in dysgenic mouse cells introduces 
a frameshift mutation intothe skeletal muscle isoform of the calcium 
channel c~ snbunit cDNA. Due to the frameshift, a stop codon is 
introduced at n 4173 that prematurely terminates the translation of 
mRNA and changes part of the topology of motif IV as well. 
6-- 
the nature and function of the skeletal muscle L-VGCC ~l 
subunit. First, due to the presence of the premature stop codon, 
the mutant transcript codes for a protein with a length of 1352 
amino acids and a molecular weight of 153,681. This is a consid- 
erable truncation compared to that of the full-length sequence 
of the a~ from normal mouse muscle (1873 amino acids, molec- 
ular weight 212,018). Second, in the mutant protein part of the 
IVSS 1, the IVSS2, the extracellular connecting loop to IVS6, the 
IVS 6 and the entire C-terminal cytoplasmic tail is missing. Some 
of these segments, in particular the IVSS1 and IVSS2, are 
well-identified integral components of the high-affinity Ca 2+ 
filtration units [24-26]; the putative E-F hand [27] on the C- 
terminal tail may also be involved in Ca 2+ binding. Based on 
hydropathy analysis and prediction of secondary structure, we 
suggest that the C-terminus of the mutant protein will be largely 
globular and localized intracellularly. Therefore, it is unlikely 
that the mutant ~] protein will and can exert calcium channel 
function. Our electrophysiological d ta are consistent with this 
since no skeletal L-type IBa was recorded in dysgenic 129DA3 
cells [11]. 
Immortalized ysgenic mouse skeletal muscle cells express 
detectable amounts of skeletal and cardiac L-VGCC ~1 subunit 
mRNAs. The expression level for the skeletal cq transcript was 
reported to be dramatically diminished compared to that ob- 
tained in normal mouse skeletal muscle cells [10]. We cannot 
understand, however, how the single point mutation around the 
middle of the mRNA could be responsible for the reduced 
mRNA levels [10]. Most likely, the decreased expression is due 
to some compensatory mechanisms activated by the altered 
Ca 2+ homeostasis of these cells. Alternatively, decreased 
mRNA stability is also possible [10,12] although it is difficult 
to understand the underlying molecular mechanisms. The pres- 
ent and previous data [10,12] are contradictory to an earlier 
description that localized the mutation of muscular dysgenesis 
in the 5'-end and flanking sequences of the skeletal muscle 
L-VGCC cq subunit gene [8]. Two other skeletal muscle L- 
VGCC subunit mRNAs; two transcripts for ~2/~ and numerous 
fl subunit ranscripts are expressed at a level similar to that 
observed in control cells. Further, this provides an explanation 
as to why expression of skeletal [8], cardiac [28] and brain [29] 
c~ cDNAs in primary cultures of mdg muscle cells always elic- 
ited Ca 2~ channel currents that were very close to the native 
behavior. 
It is tempting to speculate about possible phenotypic charac- 
teristic of dysgenic skeletal muscle in view of the causative point 
mutation and the present discovery of cardiac Ca 2+ channels. 
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Fig. 4. Electrophysiological properties of Ca 2+ currents endogenously 
expressed in dysgenic muscle cells. (A) Current traces were recorded 
from -20 to +50 mV (HP was -80 mV). (B) Current-voltage relation- 
ship of IBm. Numerous recordings are normalized and the percentage of 
peak current is depicted against membrane potential. (C) Influence of 
a calcium channel agonist Bay K 8644 on IBa. (D)fl-adrenergic stimulus 
enhances the calcium channel activity in 129DA 3cells. 
It is conceivable that the lack of excitation~contraction (E-C) 
coupling is due not only to the low level of aberrant Cqs subunits 
but also to a process that excludes the endogenous ~Z~c from 
interacting with the coupling machinery. Interestingly, overex- 
pression of cardiac Ca 2÷ channels restores a modified, cardiac- 
like E-C coupling [28] while overexpression f the ~IA [29] or 
C~,IB [30] cDNAs, which deliver sizable Ca 2+ currents, fail to 
restore E-C coupling. 
Our data provide evidence that ~c  is overexpressed in the 
129DA3 dysgenic ell line, compared to the normal 129CB3 
counterpart. This result isreminiscent tothat observed in devel- 
oping skeletal muscle [12]. Consistent with the presence of the 
Cqc transcript, we routinely recorded cardiac L-type current in 
differentiating myotubes of 129DA3 cells. Here, we have dem- 
onstrated that the IB~ recorded in dysgenic myotubes reflect he 
activity of Cqc-directed Ca 2+ channels whose electrophysiologi- 
cal, pharmacological nd fl-adrenergic regulation properties 
are the same as those of the class C-type Ca 2+ channels [31]. 
This is the first experimental evidence showing that the appear- 
ance of ~1c transcript in mdg cells gives rise to functional, 
C-type Ca 2+ channel activity. While it is possible that the level 
of expression of the endogenous ~1c, as well as the correspond- 
ing Ca 2+ channel current may be unable to provide enough 
'Ca 2. entry' to restore E-C coupling in the dysgenic ell line 
[11,32], this is unlikely since, the amount of 'trigger Ca 2+' re- 
quired to elicit a contraction is extremely small [33,34]. We 
therefore suspect that some component required for E-C cou- 
pling is missing. On the other hand Tanabe t al. [28] demon- 
strated that overexpression f cqc in dysgenic myotubes can 
restore C-type E-C coupling. The presence of cardiac L-type 
Ca 2+ channel in mdg myotubes i probably related to the etiol- 
ogy of the disorder [35] and is compensatory in nature. Thus, 
the expression of cardiac ~1c in 129DA 3 cells would be reminis- 
cent of the early stages of skeletal muscle development. 
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